台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.90
  • 漲跌
    ▼0.30
  • 漲幅
    -1.06%
  • 成交量
    701
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/14 ~ 2024/04/28     後一日»

券商獲利排行 - 2024/04/14 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.62%1,605.91,709-103.15502,1471,59728.528.129.227.9
  5.33%307.843.6264.210622612025.525.425.827.9
  2.86%162.531.51311382107227.12727.427.9
  5.19%141.466.175.3-60359528.627.329.227.9
  6.16%12220.5101.5-52146729.628.329.827.9
  5.12%118.79.9108.88287526.726.628.627.9
  2.93%117.8115.42.4451429728.327.82927.9
  10.59%115.6115.60039392826.529.427.9
  2.05%109.70109.7-188018828.5028.527.9
  3.04%106100.45.6-1311112527.927.428.327.9
  6.34%9756.140.832562427.326.62927.9
  1.93%96.20.196.1-1314217428.628.628.627.9
  3.63%88.964.524.4-54348827.826.528.427.9
  4.48%87.365.421.9-24456928.227.428.827.9
  6.24%84.554.729.820503027.126.428.227.9
  8.14%83.525.558-2963529.325.729.927.9
  3.51%83.212.570.6-63198228.928.42927.9
  4.69%82.14933-37256228.226.828.827.9
  4.21%79.815.963.9-6066628.726.32927.9
  8.35%77.445.432-1616322927.129.927.9
  2.48%75.563.5121211210027.226.927.527.9
  4.85%75.58.866.7-41115329.328.729.527.9
  1.18%74.888.1-13.3-11611323027.52727.827.9
  6.64%71.642.129.5-22153828.426.429.227.9
  10.81%67.164.62.52222028.226.729.927.9
  3.58%65.732.233.5-48176528.226.728.627.9
  3.29%63.918.94561711027.427.229.127.9
  2.98%62.949.213.6-21547528.227.628.527.9
  0.51%61.1146.6-85.6-28415744127.426.727.627.9
  2.03%60.6591.6-179110827.727.32827.9
  4.61%5920.938.1-24194429.128.329.427.9
  4.67%58.137.920.224452127.627.128.927.9
  5.56%53.927.526.518361826.926.42827.9
  4.44%51.115.335.9-29104028.827.629.127.9
  7.93%49.713.735.91524826.125.727.427.9
  5.28%47.93512.911332127.526.828.527.9
  4.53%44.736.28.5-10253528.127.328.827.9
  3.64%44.331.512.8-15284328.327.628.827.9
  3.19%42.640.42.2-7414827.827.228.227.9
  3.02%42.327.414.919513227.427.12827.9
  3.07%42.221.121.129502127.527.228.227.9
  1.47%41.255-13.739985928.628.329.227.9
  5.63%40.529.511.16272126.726.127.527.9
  9.44%39.439.400151527.826.529.127.9
  4.32%38.216.821.5-19113128.627.42927.9
  3.75%38.128.59.7-11243628.227.528.727.9
  2.41%38.121.716.3-29275628.227.728.527.9
  3.34%37.834.23.5-16254127.626.828.127.9
  3.58%37.25.431.9-2783628.928.42927.9
  4.62%36.635.610272828.327.628.927.9

券商虧損排行 - 2024/04/14 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -6.99%-381.4-67.2-314.2-1723420726.428.126.127.9
  -2.06%-3376.1-343.1-5514960027.327.227.327.9
  -3.28%-240.7-163.8-76.9-7819026927.327.826.927.9
  -6.07%-198.1-8-190.1104110629.729.728.427.9
  -6.18%-194.3-188.8-5.5-129911128.329.327.427.9
  -6.31%-176.6-171.7-4.95100952828.927.127.9
  -1.98%-175.2-39-136.2-16216432627.127.327.127.9
  -2.38%-139-104.5-34.5-2818921726.927.226.727.9
  -1.36%-136.9-47.4-89.52763588228.128.227.627.9
  -5.02%-127.2-6.1-121.1-9329526.729.726.627.9
  -5.46%-125.4-111.7-13.61682662828.827.127.9
  -5.27%-112.6-27.1-85.5-57228026.727.726.427.9
  -6.67%-102-64.6-37.4-28285627.328.926.627.9
  -6.70%-85.2-11.2-73.93943429.629.82727.9
  -4.78%-84.4-73.3-11.1-11526427.628.42727.9
  -3.00%-82.6-79.8-2.89999027.828.227.327.9
  -2.69%-81.5-29.8-51.7-882211027.528.727.327.9
  -4.97%-81.3-72.5-8.85575128.729.427.927.9
  -3.48%-80.8-82.51.7486822727.526.527.9
  -1.53%-80.5-41.9-38.6-1335719027.828.327.627.9
  -6.37%-80.1-79.3-0.80444527.928.927.127.9
  -5.01%-79.6-75.4-4.26575127.928.627.127.9
  -8.66%-76.6-59.6-17-628342627.225.127.9
  -5.45%-69.6-19.5-50.13344102929.427.427.9
  -4.17%-65-63.9-1.113574427.42826.527.9
  -6.59%-63.6-59.4-4.13343128.429.327.427.9
  -5.60%-61.8-46.1-15.714392528.32927.227.9
  -4.15%-55.8-40.3-15.5-16334927.428.226.927.9
  -5.73%-51.5-50.5-0.9132312828.827.227.9
  -3.50%-51.3-12.6-38.638511328.728.927.927.9
  -1.46%-49.1-43.1-6-635612028.128.627.827.9
  -6.72%-48-40.3-7.7-6202627.528.626.627.9
  -3.53%-47.1-33.9-13.2946372929.428.527.9
  -10.42%-46-4600161627.62926.227.9
  -7.19%-43.1-42.4-0.8-2192128.629.727.527.9
  -2.94%-43-9.2-33.836511528.728.828.227.9
  -5.12%-41.8-40.5-1.3-1293027.22826.627.9
  -8.77%-41.7-17.7-24-1071826.428.225.727.9
  -3.85%-41.4-32.1-9.211382728.228.727.627.9
  -4.67%-40.9-38.9-1.91312928.228.927.527.9
  -5.04%-40.4-18.9-21.518281028.629.127.227.9
  -5.06%-40.1-1.1-39-2643026.426.726.427.9
  -4.03%-40-20.3-19.722351228.328.827.127.9
  -1.49%-39.51.8-41.3-85129727.427.327.427.9
  -3.62%-39-24-15-21173927.628.627.227.9
  -2.04%-38.8-7.1-31.756671128.428.527.827.9
  -2.13%-38.7-8-30.75564928.328.527.627.9
  -6.22%-38-11-27-1672326.627.826.227.9
  -2.44%-35.8-1.7-34.2-4595427.227.327.127.9
  -4.23%-35.6-27.6-811301928.128.627.227.9
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章